Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoplastic Small Round Cell Tumor × Irinotecan × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 25 Pancreatic Neoplasms 15 Neuroblastoma 9 Neoplasm Metastasis 9 Colonic Neoplasms 7 Stomach Neoplasms 6 Sarcoma, Ewing 6 Rhabdomyosarcoma 5 Rectal Neoplasms 5 Neoplasms 5 Medulloblastoma 4 Esophageal Squamous Cell Carcinoma 4 Sarcoma 3 Recurrence 3 Ovarian Neoplasms 3 Osteosarcoma 3 Esophageal Neoplasms 3 Ependymoma 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Fibrolamellar hepatocellular carcinoma 2 Colorectal Adenocarcinoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2

Interventions

Vincristine 2 Temozolomide 2 PM 01183 2 temsirolimus 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 Zoledronic Acid 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Irinotecan 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 CLR1404 1 Brachytherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07328425 2026-01-12

ISG-TULIPS

Italian Sarcoma Group

Phase 2 Recruiting

Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡